Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotronik in first coronary implant of absorbable stent:

This article was originally published in Clinica

Executive Summary

Biotronik has taken a step forward in its bid to take its absorbable metal stent (AMS) to the coronary artery disease market. It has conducted the first human implant of the device, as part of its PROGRESS-AMS study. The product's safety has already been confirmed in below-the-knee arteries - the first human implant for this indication took place in December 2003, said the Berlin, Germany firm. Commenting on the coronary implant, the company said that four-month follow-up would be needed to determine the potential of the technology and to validate its expectations of moving the technology into the boundaries of coronary stenting.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059393

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel